IngentaConnect Search Results

5-fluorouracil in lethal mutagenesis of foot-and-mouth disease virus

Authors: Agudo, Rubén; Arias, Armando; Domingo, Esteban

Source: Future Medicinal Chemistry, Volume 1, Number 3, June 2009 , pp. 529-539(11)

Optimizing the treatment of chronic viral hepatitis C

Authors: François, Catherine; Castelain, Sandrine; Duverlie, Gilles; Capron, Dominique; Nguyen-Khac, Eric

Source: Expert Review of Gastroenterology and Hepatology, Volume 3, Number 6, December 2009 , pp. 607-613(7)

Rapid loss of hepatitis C virus genotype 1b from serum in patients receiving a triple treatment with telaprevir (MP-424), pegylated interferon and ribavirin for 12 weeks

Authors: Suzuki, Fumitaka; Akuta, Norio; Suzuki, Yoshiyuki; Sezaki, Hitomi; Yatsuji, Hiromi; Kawamura, Yusuke; Hosaka, Tetsuya; Kobayashi, Masahiro; Arase, Yasuji; Ikeda, Kenji; Mineta, Rie; Iwasaki, Satomi; Watahiki, Sachiyo; Kobayashi, Mariko; Miyakawa, Yuzo; Kumada, Hiromitsu

Source: Hepatology Research, Volume 39, Number 11, November 2009 , pp. 1056-1063(8)

Publisher: Blackwell Publishing

High-Pressure Homogenization for the Inactivation of Human Enteric Virus Surrogates

Authors: D'Souza, Doris H.; Su, Xiaowei; Roach, Adrienne; Harte, Federico

Source: Journal of Food Protection®, Volume 72, Number 11, November 2009 , pp. 2418-2422(5)

Publisher: International Association for Food Protection

Management of chronic hepatitis C patients who have relapsed or not responded to pegylated interferon alfa plus ribavirin

Authors: Dieterich, D. T.; Rizzetto, M.; Manns, M. P.

Source: Journal of Viral Hepatitis, Volume 16, Number 12, December 2009 , pp. 833-843(11)

Publisher: Blackwell Publishing

Plasma HCV-RNA decline in the first 48 h identifies hepatitis C virus mono-infected but not HCV/HIV-coinfected patients with an undetectable HCV viral load at week 4 of peginterferon-alfa-2a/ribavirin therapy

Authors: Arends, J. E.; Stuart, J. Cohen; Baak, L. C.; van der Ende, M. E.; van Erpecum, K. J.; Simons, C. P. M.; Boland, G. J.; van Baarle, D.; Hoepelman, A. I. M.

Source: Journal of Viral Hepatitis, Volume 16, Number 12, December 2009 , pp. 867-875(9)

Publisher: Blackwell Publishing

Ribosome Inactivating Proteins (RIPs) from Momordica charantia for Anti Viral Therapy

Authors: Puri, M.; Kaur, I.; Kanwar, R. K.; Gupta, R. C.; Chauhan, A.; Kanwar, J. R.

Source: Current Molecular Medicine, Volume 9, Number 9, December 2009 , pp. 1080-1094(15)

Publisher: Bentham Science Publishers

Predictive value of on-treatment response during full-dose antiviral therapy of patients with hepatitis C virus cirrhosis and portal hypertension

Authors: Giannini, E. G.; Basso, M.; Savarino, V.; Picciotto, A.

Source: Journal of Internal Medicine, Volume 266, Number 6, December 2009 , pp. 537-546(10)

Publisher: Blackwell Publishing

Inactivation and elimination of human enteric viruses by Pacific oysters

Authors: Mcleod, C.; Hay, B.; Grant, C.; Greening, G.; Day, D.

Source: Journal of Applied Microbiology, Volume 107, Number 6, December 2009 , pp. 1809-1818(10)

Publisher: Blackwell Publishing

Gene expression using microarrays in transplant recipients at risk of EBV lymphoproliferation after organ transplantation: Preliminary proof-of-concept

Authors: Allen, Upton; Barton, Michelle; Beyene, Joseph; Hu, Pingzhao; Khodai-Booran, Nasser; Hébert, Diane; Dipchand, Anne; Ng, Vicky; Solomon, Melinda; Grant, David; Fecteau, Annie; Ngan, Bo; Read, Stanley; Zielenska, Maria; Weitzman, Sheila

Source: Pediatric Transplantation, Volume 13, Number 8, December 2009 , pp. 990-998(9)

Publisher: Blackwell Publishing

Cyclin T1 stabilizes expression levels of HIV-1 Tat in cells

Authors: Imai, Kenichi; Asamitsu, Kaori; Victoriano, Ann Florence B.; Cueno, Marni E.; Fujinaga, Koh; Okamoto, Takashi

Source: FEBS Journal, Volume 276, Number 23, December 2009 , pp. 7124-7133(10)

Publisher: Blackwell Publishing

Emergence of single-molecule sequencing and potential for molecular diagnostic applications

Author: Milos, Patrice M

Source: Expert Review of Molecular Diagnostics, Volume 9, Number 7, October 2009 , pp. 659-666(8)

Publisher: Expert Reviews

Bridging the gap between adult and paediatric outcomes in HIV-1 vertically infected children: a single-centre comparison with adult data

Authors: Monpoux, F; Puglièse, P; Berthier, F; Cottalorda, J; Pradier, C

Source: Acta Pædiatrica, Volume 98, Number 11, November 2009 , pp. 1787-1792(6)

Publisher: Blackwell Publishing

Anti-poliovirus activity of Baccharis dracunculifolia and propolis by cell viability determination and real-time PCR

Authors: Búfalo, M.C.; Figueiredo, A.S.; de Sousa, J.P.B.; Candeias, J.M.G.; Bastos, J.K.; Sforcin, J.M.

Source: Journal of Applied Microbiology, Volume 107, Number 5, November 2009 , pp. 1669-1680(12)

Publisher: Blackwell Publishing

Sindbis virus as a model for studies of conformational changes in a metastable virus and the role of conformational changes in in vitro antibody neutralisation

Authors: Hernandez, Raquel; Paredes, Angel

Source: Reviews in Medical Virology, Volume 19, Number 5, September 2009 , pp. 257-272(16)

Publisher: John Wiley & Sons, Ltd.

A randomized trial of 24 versus 48 weeks of peginterferon α-2a in patients infected with chronic hepatitis C virus genotype 2 or low viral load genotype 1: a multicenter national study in Japan

Authors: Iwasaki, Yoshiaki; Shiratori, Yasushi; Hige, Shuhei; Nishiguchi, Shuhei; Takagi, Hitoshi; Onji, Morikazu; Yoshida, Haruhiko; Izumi, Namiki; Kohgo, Yutaka; Yamamoto, Kyosuke; Sato, Nobuhiro; Shibuya, Akitaka; Saito, Hidetsugu; Sata, Michio; Suzuki, Kazuyuki; Kaneko, Shuichi; Moriyama, Mitsuhiko; Omata, Masao

Source: Hepatology International, Volume 3, Number 3, September 2009 , pp. 468-479(12)

Publisher: Springer

Low viraemia at enrollment in children with chronic hepatitis C favours spontaneous viral clearance

Authors: Chen, S.-T.; Ni, Y.-H.; Chen, P.-J.; Chen, H.-L.; Jeng, Y.-M.; Lu, M.-Y.; Wu, J.-F.; Hsu, H.-Y.; Chang, M.-H.

Source: Journal of Viral Hepatitis, Volume 16, Number 11, November 2009 , pp. 796-801(6)

Publisher: Blackwell Publishing

Pharmacokinetic variability of antiretroviral drugs and correlation with virological outcome: 2 years of experience in routine clinical practice

Authors: Fabbiani, Massimiliano; Di Giambenedetto, Simona; Bracciale, Laura; Bacarelli, Alessandra; Ragazzoni, Enzo; Cauda, Roberto; Navarra, Pierluigi; De Luca, Andrea

Source: Journal of Antimicrobial Chemotherapy, Volume 64, Number 1, 14 July 2009 , pp. 109-117(9)

Publisher: Oxford University Press

Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study

Authors: Landman, Roland; Capitant, Catherine; Descamps, Diane; Chazallon, Corine; Peytavin, Gilles; Katlama, Christine; Pialoux, Gilles; Bentata, Michelle; Brun-Vzinet, Francoise; Aboulker, Jean-Pierre; Yni, Patrick

Source: Journal of Antimicrobial Chemotherapy, Volume 64, Number 1, 14 July 2009 , pp. 118-125(8)

Publisher: Oxford University Press

A randomized trial of two-drug versus three-drug tenofovir-containing maintenance regimens in virologically controlled HIV-1 patients

Authors: Girard, Pierre-Marie; Cabi, Andr; Michelet, Christian; Verdon, Renaud; Katlama, Christine; Merci, Patrick; Morand-Joubert, Laurence; Ptour, Pascal; Monchecourt, Franoise; Chne, Genevive; Trylesinski, Aldo

Source: Journal of Antimicrobial Chemotherapy, Volume 64, Number 1, 14 July 2009 , pp. 126-134(9)

Publisher: Oxford University Press